Advertisement Laureate Pharma appoints new vice president, Business Development - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Laureate Pharma appoints new vice president, Business Development

Laureate Pharma, a biopharmaceutical company engaged in protein production has appointed Steven Johnson as the vice president of Business Development of the company.

Most recently, Johnson served for Lonza as the vice president of Global Business Development, and previously as vice president of Sales and Business Development, North America.

Laureate Pharma CEO Michael Griffith said that Steve brings a proven track record of sales management in the biologics market combined with extensive senior relationships.

“He is an industry leader and brings to Laureate Pharma an impressive background that includes broad international business development experience in contract manufacturing of monoclonal antibodies, biopharmaceuticals and chemical active pharmaceutical ingredients,” Griffith said.